[{"Assets_0_Q3_USD":27484000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":5118400000.0,"NetIncomeLossConverted_1_Q3_USD":1545900000.0,"NetIncomeLossConverted_3_Q3_USD":4448800000.0,"RevenuesConverted_1_Q3_USD":3600100000.0,"RevenuesConverted_3_Q3_USD":10706600000.0,"StockholdersEquity_0_Q3_USD":13995900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":184200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":190500000.0,"StockholdersEquityConverted_0_Q3_USD":13991800000.0,"EarningsPerShareBasic_1_Q3_USD":8.4,"EarningsPerShareBasic_3_Q3_USD":23.38,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":184000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":190300000.0,"EarningsPerShareDiluted_1_Q3_USD":8.39,"EarningsPerShareDiluted_3_Q3_USD":23.35,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20191022"}]